News
05-15-2014, 06:10 AM
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, today reported financial results for the three months ended March 31, 2014.
More... (http://www.news-medical.net/news/20140515/EntreMed-reports-net-loss-of-2415M-in-first-quarter-2014.aspx)
More... (http://www.news-medical.net/news/20140515/EntreMed-reports-net-loss-of-2415M-in-first-quarter-2014.aspx)